Showing results (51-60 of 228) with videos related to
Sort By:
Pageof 23
Parkinsonism & Related Disorders|March 8, 2008
Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trialDaniel Truong, Cynthia Comella, Hubert H Fernandez, et al.Current Neurology and Neuroscience Reports|August 18, 2019
Tardive Dyskinesia: Treatment UpdateDivya Arya, Tarannum Khan, Adam J Margolius, et al.Drugs & Aging|April 17, 2007
When should levodopa therapy be initiated in patients with Parkinson's disease?Irene A C Halkias, Ihtsham Haq, Zhigao Huang, et al.The Neurologist|January 6, 2012
Nonmotor manifestations in Parkinson diseaseOscar Bernal-Pacheco, Natlada Limotai, Criscely L Go, et al.The Neurologist|September 13, 2007
Pearls in patient selection for deep brain stimulationRamon L Rodriguez, Hubert H Fernandez, Ihtsham Haq, et al.Parkinsonism & Related Disorders|February 8, 2011
Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patientsRamon A Gil, Nelson Hwynn, Thomas Fabian, et al.The Neurologist|March 14, 2007
The "chair test" to aid in the diagnosis of psychogenic gait disordersMichael S Okun, Ramon L Rodriguez, Kelly D Foote, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|April 30, 2021
Genetic updates on paroxysmal dyskinesiasJames Y Liao, Philippe A Salles, Umar A Shuaib, et al.The Journal of Clinical Psychiatry|June 29, 2002
Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodiesHubert H Fernandez, Martha E Trieschmann, Monica A Burke, et al.Brain Imaging and Behavior|December 19, 2024
Parkinson's disease subtypes and their association with probable rapid eye movement sleep behavior disorder severity: a brainstem tractography and machine learning investigationAnupa A Vijayakumari, Ken E Sakaie, Hubert H Fernandez, et al.Pageof 23